The pathogenesis and potential therapeutic targets in sepsis
MedComm · 2023-12 · 4 (6)
DOI: 10.1002/mco2.418 ↗At a glance
Übersichtsarbeit in MedComm, published online on 2023-11-20. Written by Wendan Zhang and 7 co-authors. Institution: Shanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research Shanghai University of Traditi…. Cited 75 times so far (Crossref); 457 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.
Topics: Sepsis
Abstract (original language)
Sepsis is defined as “a life‐threatening organ dysfunction caused by dysregulated host systemic inflammatory and immune response to infection.” At present, sepsis continues to pose a grave healthcare concern worldwide. Despite the use of supportive measures in treating traditional sepsis, such as intravenous fluids, vasoactive substances, and oxygen plus antibiotics to eradicate harmful pathogens, there is an ongoing increase in both the morbidity and mortality associated with sepsis during clinical interventions. Therefore, it is urgent to design specific pharmacologic agents for the treatment of sepsis and convert them into a novel targeted treatment strategy. Herein, we provide an overview of the molecular mechanisms that may be involved in sepsis, such as the inflammatory response, immune dysfunction, complement deactivation, mitochondrial damage, and endoplasmic reticulum stress. Additionally, we highlight important targets involved in sepsis‐related regulatory mechanisms, including GSDMD, HMGB1, STING, and SQSTM1, among others. We summarize the latest advancements in potential therapeutic drugs that specifically target these signaling pathways and paramount targets, covering both preclinical studies and clinical trials. In addition, this review provides a detailed description of the crosstalk and function between signaling pathways and vital targets, which provides more opportunities for the clinical development of new treatments for sepsis.
Subjects
Author keywords
Authors and institutions
- Shanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research Shanghai University of Traditional Chinese Medicine Shanghai China.
- Faculty of Pediatrics National Engineering Laboratory for Birth defects prevention and control of key technology Beijing Key Laboratory of Pediatric Organ Failure the Chinese PLA General Hospital Beijing China.
- Shandong Provincial Key Laboratory for Rheumatic Disease and Translational Medicine The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Jinan Shandong China.
- Department of Phytochemistry School of Pharmacy Second Military Medical University Shanghai China.
- The Research Center for Traditional Chinese Medicine Shanghai Institute of Infectious Diseases and Biosecurity Shanghai University of Traditional Chinese Medicine Shanghai China.
- Institute of Medicinal Plant Development Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
ORCID profiles: Sanhong Liu
Funding
- National Natural Science Foundation of China
Cite
APA
Zhang, W., Jiang, H., Wu, G., Huang, P., Wang, H., An, H., Liu, S., & Zhang, W. (2023). The pathogenesis and potential therapeutic targets in sepsis. MedComm, 4(6). https://doi.org/10.1002/mco2.418
Vancouver
Zhang W, Jiang H, Wu G, Huang P, Wang H, An H, et al. The pathogenesis and potential therapeutic targets in sepsis. MedComm. 2023;4(6). doi:10.1002/mco2.418
BibTeX
@article{Zhang2023,
author = {Zhang, Wendan and Jiang, Honghong and Wu, Gaosong and Huang, Pengli and Wang, Haonan and An, Huazhasng and Liu, Sanhong and Zhang, Weidong},
title = {The pathogenesis and potential therapeutic targets in sepsis},
journal = {MedComm},
year = {2023},
volume = {4},
number = {6},
doi = {10.1002/mco2.418}
}
EUVIMED